The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

BMC Cancer · 2015 · PMC4464713 · PMID 26062614

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

In analyses assessing risk of recurrences according to established patient-and tumor characteristics, clinically detected DCIS were more prone to recur locally (HR 1.78 (1.04–3.07), larger DCIS lesions were correlated to a borderline significant increased risk of in situ IBEs but not invasive IBEs (HR 1.88 (0.97–3.62) and 0.64 (0.30–1.34)), respectively.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.